Corbus Pharmaceuticals Holdings, Inc.·4

Jun 17, 4:40 PM ET

CATLIN AVERY W 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jun 17, 2021

Insider Transaction Report

Form 4
Period: 2021-06-17
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-17+58,20058,200 total
    Exercise: $2.07Exp: 2031-06-17Common Stock (58,200 underlying)
  • Award

    Stock Option (right to buy)

    2021-06-17+58,20058,200 total
    Exercise: $2.07Exp: 2031-06-17Common Stock (58,200 underlying)
Footnotes (2)
  • [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
  • [F2]Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION